Latest News & Features
Big Pharma
The COVID-19 pandemic has seen the fundamental principles of the IP system called into question. How can we go on as before? 5 June 2020
Big Pharma
The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme. 5 June 2020
Asia
IP firm Rouse will collaborate with life sciences service provider Codex to support companies looking to enter the Chinese market. 4 June 2020
Big Pharma
In a victory for Mylan, the English High Court has rejected Israel-based pharmaceutical company Neurim’s attempt to delay a generic version of its insomnia medication. 4 June 2020
Americas
The leaders of some of the world’s largest pharma companies appear to be resistant to a World Health Organization voluntary pool aimed at making vaccines, tests, treatments and other health technologies to fight COVID-19 accessible to all. 4 June 2020
Europe
Israeli generic drugmaker Teva Pharmaceuticals must face infringement claims related to an asthma inhaler, an English judge has ruled. 3 June 2020
Americas
Gilead Sciences has persuaded the US Patent Trial and Appeal Board to review an antiviral patent owned by the University of Minnesota. 2 June 2020
Americas
The US Food and Drug Administration has warned a US Court of Appeals for the DC Circuit decision awarding market exclusivity to Eagle Pharmaceuticals for a cancer drug will have “grave” consequences for patient access. 29 May 2020
Africa
The World Health Organization has launched a COVID-19 technology pool, with 37 countries and multiple international partners and institutions rallying together to support the initiative. 29 May 2020
Americas
The PrEP4All campaign has argued that the US government should own joint patent rights for remdesivir, the Gilead Sciences antiviral which is the only drug approved anywhere for treating COVID-19. 28 May 2020